课题基金 / 基金详情

Emory Alzheimer's Disease Research Center

Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
批准号:
10408030
负责人:
DAVID WEINSHENKER
金额:
$15.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-04-30

项目摘要

项目成果

DAVID WEINSHENKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
  • 批准号:
    10525513
  • 项目类别:
  • 资助金额:
    $153.16万
  • 财政年份:
    2022
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    9981143
  • 项目类别:
  • 资助金额:
    $47.19万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    10456900
  • 项目类别:
  • 资助金额:
    $46.38万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    10669138
  • 项目类别:
  • 资助金额:
    $46.38万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
海外基金